Adherence to roflumilast under dose-escalation strategy in Korean patients with COPD

BACKGROUND: Frequent development of adverse events and consequent low adherence are major barriers in the wide use of roflumilast. Asian patients may be more susceptible to adverse events due to low BMI. In this study, we aimed to determine if a dose-escalation strategy is useful to improve the drug...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Int J Chron Obstruct Pulmon Dis
Main Authors: Park, Tai Sun, Kang, Jieun, Lee, Jae Seung, Oh, Yeon-Mok, Lee, Sang-Do, Lee, Sei Won
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2019
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6580853/
https://ncbi.nlm.nih.gov/pubmed/31354255
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S191033
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki